Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry

The current flow cytometric analysis of blood and bone marrow samples for diagnosis of acute myeloid leukemia (AML) relies heavily on manual intervention in the processing and analysis steps, introducing significant subjectivity into resulting diagnoses and necessitating highly trained personnel. Fu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Modern pathology 2024-01, Vol.37 (1), p.100373-100373, Article 100373
Hauptverfasser: Lewis, Joshua E, Cooper, Lee A D, Jaye, David L, Pozdnyakova, Olga
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100373
container_issue 1
container_start_page 100373
container_title Modern pathology
container_volume 37
creator Lewis, Joshua E
Cooper, Lee A D
Jaye, David L
Pozdnyakova, Olga
description The current flow cytometric analysis of blood and bone marrow samples for diagnosis of acute myeloid leukemia (AML) relies heavily on manual intervention in the processing and analysis steps, introducing significant subjectivity into resulting diagnoses and necessitating highly trained personnel. Furthermore, concurrent molecular characterization via cytogenetics and targeted sequencing can take multiple days, delaying patient diagnosis and treatment. Attention-based multi-instance learning models (ABMILMs) are deep learning models that make accurate predictions and generate interpretable insights regarding the classification of a sample from individual events/cells; nonetheless, these models have yet to be applied to flow cytometry data. In this study, we developed a computational pipeline using ABMILMs for the automated diagnosis of AML cases based exclusively on flow cytometric data. Analysis of 1820 flow cytometry samples shows that this pipeline provides accurate diagnoses of acute leukemia (area under the receiver operating characteristic curve [AUROC] 0.961) and accurately differentiates AML vs B- and T-lymphoblastic leukemia (AUROC 0.965). Models for prediction of 9 cytogenetic aberrancies and 32 pathogenic variants in AML provide accurate predictions, particularly for t(15;17)(PML::RARA) [AUROC 0.929], t(8;21)(RUNX1::RUNX1T1) (AUROC 0.814), and NPM1 variants (AUROC 0.807). Finally, we demonstrate how these models generate interpretable insights into which individual flow cytometric events and markers deliver optimal diagnostic utility, providing hematopathologists with a data visualization tool for improved data interpretation, as well as novel biological associations between flow cytometric marker expression and cytogenetic/molecular variants in AML. Our study is the first to illustrate the feasibility of using deep learning-based analysis of flow cytometric data for automated AML diagnosis and molecular characterization.
doi_str_mv 10.1016/j.modpat.2023.100373
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2886329340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2886329340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-dc9c6a04fb9afbecc9ba1551671b7fcda0571af40a6e9f6aad7ce3bca004b9b93</originalsourceid><addsrcrecordid>eNo9kM1O3DAUhS1UVAbaN6iQl91kuI7jJF4OQylIg9iUtXXj3ICnSTzYjtD06ZvRAKsjHZ0f6WPsh4ClAFFebZeDb3eYljnkcrZAVvKELYSSkEFeqy9sAbWWmdQqP2PnMW4BRKHq_Cs7k5XOFahywabVlPyAiVp-Q7TjG8IwuvE5u8Z48Bw-jz66yHFs-YPvyU49Br5-wYA2UXD_MDk_ct_xlZ0S8Yc99d6189D0lwaH_CnOc_y29298vZ-_KIX9N3baYR_p-7tesKfbX3_Wd9nm8ff9erXJrFQyZa3VtkQoukZj15C1ukGhlCgr0VSdbRFUJbArAEvSXYnYVpZkYxGgaHSj5QX7edzdBf86UUxmcNFS3-NIfoomr-tS5loWMEeLY9QGH2OgzuyCGzDsjQBzAG625gjcHICbI_C5dvn-MDUDtZ-lD8LyP3VHgRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2886329340</pqid></control><display><type>article</type><title>Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Lewis, Joshua E ; Cooper, Lee A D ; Jaye, David L ; Pozdnyakova, Olga</creator><creatorcontrib>Lewis, Joshua E ; Cooper, Lee A D ; Jaye, David L ; Pozdnyakova, Olga</creatorcontrib><description>The current flow cytometric analysis of blood and bone marrow samples for diagnosis of acute myeloid leukemia (AML) relies heavily on manual intervention in the processing and analysis steps, introducing significant subjectivity into resulting diagnoses and necessitating highly trained personnel. Furthermore, concurrent molecular characterization via cytogenetics and targeted sequencing can take multiple days, delaying patient diagnosis and treatment. Attention-based multi-instance learning models (ABMILMs) are deep learning models that make accurate predictions and generate interpretable insights regarding the classification of a sample from individual events/cells; nonetheless, these models have yet to be applied to flow cytometry data. In this study, we developed a computational pipeline using ABMILMs for the automated diagnosis of AML cases based exclusively on flow cytometric data. Analysis of 1820 flow cytometry samples shows that this pipeline provides accurate diagnoses of acute leukemia (area under the receiver operating characteristic curve [AUROC] 0.961) and accurately differentiates AML vs B- and T-lymphoblastic leukemia (AUROC 0.965). Models for prediction of 9 cytogenetic aberrancies and 32 pathogenic variants in AML provide accurate predictions, particularly for t(15;17)(PML::RARA) [AUROC 0.929], t(8;21)(RUNX1::RUNX1T1) (AUROC 0.814), and NPM1 variants (AUROC 0.807). Finally, we demonstrate how these models generate interpretable insights into which individual flow cytometric events and markers deliver optimal diagnostic utility, providing hematopathologists with a data visualization tool for improved data interpretation, as well as novel biological associations between flow cytometric marker expression and cytogenetic/molecular variants in AML. Our study is the first to illustrate the feasibility of using deep learning-based analysis of flow cytometric data for automated AML diagnosis and molecular characterization.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1016/j.modpat.2023.100373</identifier><identifier>PMID: 37925056</identifier><language>eng</language><publisher>United States</publisher><ispartof>Modern pathology, 2024-01, Vol.37 (1), p.100373-100373, Article 100373</ispartof><rights>Copyright © 2023 United States &amp; Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-dc9c6a04fb9afbecc9ba1551671b7fcda0571af40a6e9f6aad7ce3bca004b9b93</citedby><cites>FETCH-LOGICAL-c353t-dc9c6a04fb9afbecc9ba1551671b7fcda0571af40a6e9f6aad7ce3bca004b9b93</cites><orcidid>0000-0001-8376-0344</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37925056$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lewis, Joshua E</creatorcontrib><creatorcontrib>Cooper, Lee A D</creatorcontrib><creatorcontrib>Jaye, David L</creatorcontrib><creatorcontrib>Pozdnyakova, Olga</creatorcontrib><title>Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><description>The current flow cytometric analysis of blood and bone marrow samples for diagnosis of acute myeloid leukemia (AML) relies heavily on manual intervention in the processing and analysis steps, introducing significant subjectivity into resulting diagnoses and necessitating highly trained personnel. Furthermore, concurrent molecular characterization via cytogenetics and targeted sequencing can take multiple days, delaying patient diagnosis and treatment. Attention-based multi-instance learning models (ABMILMs) are deep learning models that make accurate predictions and generate interpretable insights regarding the classification of a sample from individual events/cells; nonetheless, these models have yet to be applied to flow cytometry data. In this study, we developed a computational pipeline using ABMILMs for the automated diagnosis of AML cases based exclusively on flow cytometric data. Analysis of 1820 flow cytometry samples shows that this pipeline provides accurate diagnoses of acute leukemia (area under the receiver operating characteristic curve [AUROC] 0.961) and accurately differentiates AML vs B- and T-lymphoblastic leukemia (AUROC 0.965). Models for prediction of 9 cytogenetic aberrancies and 32 pathogenic variants in AML provide accurate predictions, particularly for t(15;17)(PML::RARA) [AUROC 0.929], t(8;21)(RUNX1::RUNX1T1) (AUROC 0.814), and NPM1 variants (AUROC 0.807). Finally, we demonstrate how these models generate interpretable insights into which individual flow cytometric events and markers deliver optimal diagnostic utility, providing hematopathologists with a data visualization tool for improved data interpretation, as well as novel biological associations between flow cytometric marker expression and cytogenetic/molecular variants in AML. Our study is the first to illustrate the feasibility of using deep learning-based analysis of flow cytometric data for automated AML diagnosis and molecular characterization.</description><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kM1O3DAUhS1UVAbaN6iQl91kuI7jJF4OQylIg9iUtXXj3ICnSTzYjtD06ZvRAKsjHZ0f6WPsh4ClAFFebZeDb3eYljnkcrZAVvKELYSSkEFeqy9sAbWWmdQqP2PnMW4BRKHq_Cs7k5XOFahywabVlPyAiVp-Q7TjG8IwuvE5u8Z48Bw-jz66yHFs-YPvyU49Br5-wYA2UXD_MDk_ct_xlZ0S8Yc99d6189D0lwaH_CnOc_y29298vZ-_KIX9N3baYR_p-7tesKfbX3_Wd9nm8ff9erXJrFQyZa3VtkQoukZj15C1ukGhlCgr0VSdbRFUJbArAEvSXYnYVpZkYxGgaHSj5QX7edzdBf86UUxmcNFS3-NIfoomr-tS5loWMEeLY9QGH2OgzuyCGzDsjQBzAG625gjcHICbI_C5dvn-MDUDtZ-lD8LyP3VHgRs</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Lewis, Joshua E</creator><creator>Cooper, Lee A D</creator><creator>Jaye, David L</creator><creator>Pozdnyakova, Olga</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8376-0344</orcidid></search><sort><creationdate>202401</creationdate><title>Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry</title><author>Lewis, Joshua E ; Cooper, Lee A D ; Jaye, David L ; Pozdnyakova, Olga</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-dc9c6a04fb9afbecc9ba1551671b7fcda0571af40a6e9f6aad7ce3bca004b9b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lewis, Joshua E</creatorcontrib><creatorcontrib>Cooper, Lee A D</creatorcontrib><creatorcontrib>Jaye, David L</creatorcontrib><creatorcontrib>Pozdnyakova, Olga</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lewis, Joshua E</au><au>Cooper, Lee A D</au><au>Jaye, David L</au><au>Pozdnyakova, Olga</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry</atitle><jtitle>Modern pathology</jtitle><addtitle>Mod Pathol</addtitle><date>2024-01</date><risdate>2024</risdate><volume>37</volume><issue>1</issue><spage>100373</spage><epage>100373</epage><pages>100373-100373</pages><artnum>100373</artnum><issn>0893-3952</issn><eissn>1530-0285</eissn><abstract>The current flow cytometric analysis of blood and bone marrow samples for diagnosis of acute myeloid leukemia (AML) relies heavily on manual intervention in the processing and analysis steps, introducing significant subjectivity into resulting diagnoses and necessitating highly trained personnel. Furthermore, concurrent molecular characterization via cytogenetics and targeted sequencing can take multiple days, delaying patient diagnosis and treatment. Attention-based multi-instance learning models (ABMILMs) are deep learning models that make accurate predictions and generate interpretable insights regarding the classification of a sample from individual events/cells; nonetheless, these models have yet to be applied to flow cytometry data. In this study, we developed a computational pipeline using ABMILMs for the automated diagnosis of AML cases based exclusively on flow cytometric data. Analysis of 1820 flow cytometry samples shows that this pipeline provides accurate diagnoses of acute leukemia (area under the receiver operating characteristic curve [AUROC] 0.961) and accurately differentiates AML vs B- and T-lymphoblastic leukemia (AUROC 0.965). Models for prediction of 9 cytogenetic aberrancies and 32 pathogenic variants in AML provide accurate predictions, particularly for t(15;17)(PML::RARA) [AUROC 0.929], t(8;21)(RUNX1::RUNX1T1) (AUROC 0.814), and NPM1 variants (AUROC 0.807). Finally, we demonstrate how these models generate interpretable insights into which individual flow cytometric events and markers deliver optimal diagnostic utility, providing hematopathologists with a data visualization tool for improved data interpretation, as well as novel biological associations between flow cytometric marker expression and cytogenetic/molecular variants in AML. Our study is the first to illustrate the feasibility of using deep learning-based analysis of flow cytometric data for automated AML diagnosis and molecular characterization.</abstract><cop>United States</cop><pmid>37925056</pmid><doi>10.1016/j.modpat.2023.100373</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-8376-0344</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-3952
ispartof Modern pathology, 2024-01, Vol.37 (1), p.100373-100373, Article 100373
issn 0893-3952
1530-0285
language eng
recordid cdi_proquest_miscellaneous_2886329340
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T20%3A56%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Automated%20Deep%20Learning-Based%20Diagnosis%20and%20Molecular%20Characterization%20of%20Acute%20Myeloid%20Leukemia%20Using%20Flow%20Cytometry&rft.jtitle=Modern%20pathology&rft.au=Lewis,%20Joshua%20E&rft.date=2024-01&rft.volume=37&rft.issue=1&rft.spage=100373&rft.epage=100373&rft.pages=100373-100373&rft.artnum=100373&rft.issn=0893-3952&rft.eissn=1530-0285&rft_id=info:doi/10.1016/j.modpat.2023.100373&rft_dat=%3Cproquest_cross%3E2886329340%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2886329340&rft_id=info:pmid/37925056&rfr_iscdi=true